Linking Alzheimer's disease to brain injuries and synaptic damage
Connecting Alzheimer's Disease to Traumatic Synaptic Neurodegeneration
This study is looking at how a past traumatic brain injury might lead to Alzheimer's disease, and it aims to find ways to spot early signs of brain changes so that we can help people who are at risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11071959 on NIH RePORTER |
What this research studies
This research investigates the connection between traumatic brain injury (TBI) and the development of Alzheimer's disease (AD). It focuses on understanding how TBI can trigger neurodegenerative processes that lead to dementia, particularly during the early, preclinical stages of AD. Using a novel imaging platform called SEQUIN, researchers aim to monitor synaptic injury, which is a critical factor in the progression of AD. By identifying the mechanisms behind synaptic loss, the study seeks to uncover potential early intervention strategies for at-risk individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced traumatic brain injuries, particularly those under the age of 45, and are at risk for developing Alzheimer's disease.
Not a fit: Patients who have not experienced any form of traumatic brain injury or those with advanced Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or delaying the onset of Alzheimer's disease in individuals with a history of traumatic brain injury.
How similar studies have performed: Previous research has shown promising results in understanding the link between traumatic brain injury and neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Kummer, Terrance T — Washington University
- Study coordinator: Kummer, Terrance T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.